MedPath
HSA Product

PROPOFOL-LIPURO INJECTION 1% w/v

Product approved by Health Sciences Authority (SG)

Basic Information

PROPOFOL-LIPURO INJECTION 1% w/v

EMULSION

Regulatory Information

SIN12266P

April 25, 2003

Prescription Only

Therapeutic

INTRAVENOUS

August 10, 2023

June 4, 2025

XN01AX10

Company Information

B. BRAUN SINGAPORE PTE LTD

B. BRAUN SINGAPORE PTE LTD

Active Ingredients

PROPOFOL

Strength: 10 mg/ml

Detailed Information

Contraindications

**Contraindications** Propofol-®Lipuro 1 % (10 mg/ml) must not be used - in patients with known hypersensitivity to propofol or to any of the constituents of the emulsion, see also section “Special warnings and precautions for use” below – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_, - in children younger than 3 years for induction and maintenance of anaesthesia, - in patients of 16 years of age or younger for sedation in intensive care, - in high doses during pregnancy, and obstetric anaesthesia with the exception of termination of pregnancy.

Indication Information

**Indications** Propofol-®Lipuro 1 % (10 mg/ml) is a short-acting intravenous general anaesthetic for - induction and maintenance of general anaesthesia in adults and for use in children above 3 years of age; - sedation of ventilated adult patients (above 16 years of age) in the intensive care unit; and - sedation of adult patients (above 16 years of age) for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia.

© Copyright 2025. All Rights Reserved by MedPath